Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
S. Kawakami
Observed name:
Satoru Kawakami
Institutions:
Saitama Medical Center, Saitama Medical University,
Saitama Medical University
Observed institutions:
Saitama Medical Center, Saitama Medical University,
Saitama Medical University
ORCID:
0000-0001-6319-3821
Observed ORCID:
0000-0001-6319-3821
OpenAlex ID:
A5015379188
142P The predictive biomarker for immune-related adverse events (irAEs) in patients with metastatic renal cell carcinoma treated with the combination therapy of nivolumab plus ipilimumab: Musashino study-irAE
2022
·
R. Kizawa
, M. Kuno
, et al.
·
Annals of Oncology
·
2
PDF
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study
2026
·
Atsushi Mizokami
, Rikiya Matsumoto
, et al.
·
The Prostate
·
1
PDF
144P Association between immune-related adverse events and survival in metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
2022
·
T. Hayase
, S. Washino
, et al.
·
Annals of Oncology
·
1
PDF
139MO Prognostic significance of the mechanism of inflammatory markers in advanced renal cell carcinoma patients treated with nivolumab plus ipilimumab
2022
·
T. Nakayama
, H. Takeshita
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
4
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type